Page last updated: 2024-09-03

imatinib mesylate and Respiratory Tract Infections

imatinib mesylate has been researched along with Respiratory Tract Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amat, P; Collado, M; Hernández-Boluda, JC; Marugán, I; Roda, D; Tormo, M	1

Other Studies

1 other study(ies) available for imatinib mesylate and Respiratory Tract Infections

Article	Year
Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia. Leukemia research, 2009, Volume: 33, Issue:4 Topics: Aged; Analgesics, Non-Narcotic; Anemia, Aplastic; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mycoses; Piperazines; Pyrimidines; Remission Induction; Respiratory Tract Infections	2009

Article

Year

Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia.

Leukemia research, 2009, Volume: 33, Issue:4

Topics: Aged; Analgesics, Non-Narcotic; Anemia, Aplastic; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mycoses; Piperazines; Pyrimidines; Remission Induction; Respiratory Tract Infections

2009